{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T02:45:59Z","timestamp":1794192359487,"version":"4.8.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T00:00:00Z","timestamp":1677715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T00:00:00Z","timestamp":1677715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Clonal haematopoiesis of indeterminate potential (CHIP) is a predisposition to haematological malignancy whose relationship with chronic inflammatory diseases, such as cardiovascular diseases, has been highlighted. Here, we aimed to investigate the CHIP emergence rate and its association with inflammatory markers in Beh\u00e7et\u2019s disease (BD).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We performed targeted next-generation sequencing to detect the presence of CHIP using peripheral blood cells from 117 BD patients and 5004 healthy controls between March 2009 and September 2021 and analysed the association between CHIP and inflammatory markers.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>CHIP was detected in 13.9% of patients in the control group and 11.1% of patients in the BD group, indicating no significant intergroup difference. Among the BD patients of our cohort, five variants (<jats:italic>DNMT3A<\/jats:italic>, <jats:italic>TET2<\/jats:italic>, <jats:italic>ASXL1<\/jats:italic>, <jats:italic>STAG2<\/jats:italic>, and <jats:italic>IDH2<\/jats:italic>) were detected. <jats:italic>DNMT3A<\/jats:italic> mutations were the most common, followed by <jats:italic>TET2<\/jats:italic> mutations. CHIP carriers with BD had a higher serum platelet count, erythrocyte sedimentation rate, and C-reactive protein level; older age; and lower serum albumin level at diagnosis than non-CHIP carriers with BD. However, the significant association between inflammatory markers and CHIP disappeared after the adjustment for various variables, including age. Moreover, CHIP was not an independent risk factor for poor clinical outcomes in patients with BD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Although BD patients did not have higher CHIP emergence rates than the general population, older age and degree of inflammation in BD were associated with CHIP emergence.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13075-023-03014-w","type":"journal-article","created":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T09:05:06Z","timestamp":1677747906000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Interplay between chronic inflammation and clonal haematopoiesis of indeterminate potential in Beh\u00e7et\u2019s disease"],"prefix":"10.1186","volume":"25","author":[{"given":"Jihye","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyul","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiwoo","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I Seul","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Il","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Hee","family":"Cheon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,2]]},"reference":[{"issue":"1","key":"3014_CR1","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1053\/j.seminhematol.2016.10.002","volume":"54","author":"M Jan","year":"2017","unstructured":"Jan M, Ebert BL, Jaiswal S. Clonal hematopoiesis. Semin Hematol. 2017;54(1):43\u201350.","journal-title":"Semin Hematol"},{"issue":"26","key":"3014_CR2","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","volume":"371","author":"G Genovese","year":"2014","unstructured":"Genovese G, Kahler AK, Handsaker RE, Lindberg J, Rose SA, Bakhoum SF, Chambert K, Mick E, Neale BM, Fromer M, et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J Med. 2014;371(26):2477\u201387.","journal-title":"N Engl J Med"},{"issue":"2","key":"3014_CR3","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1701719","volume":"377","author":"S Jaiswal","year":"2017","unstructured":"Jaiswal S, Natarajan P, Silver AJ, Gibson CJ, Bick AG, Shvartz E, McConkey M, Gupta N, Gabriel S, Ardissino D, et al. Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease. N Engl J Med. 2017;377(2):111\u201321.","journal-title":"N Engl J Med"},{"issue":"7569","key":"3014_CR4","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nature15252","volume":"525","author":"Q Zhang","year":"2015","unstructured":"Zhang Q, Zhao K, Shen Q, Han Y, Gu Y, Li X, Zhao D, Liu Y, Wang C, Zhang X, et al. Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6. Nature. 2015;525(7569):389\u201393.","journal-title":"Nature"},{"issue":"6327","key":"3014_CR5","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1126\/science.aag1381","volume":"355","author":"JJ Fuster","year":"2017","unstructured":"Fuster JJ, MacLauchlan S, Zuriaga MA, Polackal MN, Ostriker AC, Chakraborty R, Wu CL, Sano S, Muralidharan S, Rius C, et al. Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice. Science. 2017;355(6327):842\u20137.","journal-title":"Science"},{"issue":"22","key":"3014_CR6","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1182\/bloodadvances.2018020222","volume":"2","author":"DP Steensma","year":"2018","unstructured":"Steensma DP. Clinical consequences of clonal hematopoiesis of indeterminate potential. Blood Adv. 2018;2(22):3404\u201310.","journal-title":"Blood Adv"},{"issue":"8","key":"3014_CR7","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41408-018-0107-2","volume":"8","author":"P Savola","year":"2018","unstructured":"Savola P, Lundgren S, Keranen MAI, Almusa H, Ellonen P, Leirisalo-Repo M, Kelkka T, Mustjoki S. Clonal hematopoiesis in patients with rheumatoid arthritis. Blood Cancer J. 2018;8(8):69.","journal-title":"Blood Cancer J"},{"issue":"6","key":"3014_CR8","doi-asserted-by":"publisher","first-page":"e264","DOI":"10.3324\/haematol.2019.223305","volume":"105","author":"CM Arends","year":"2020","unstructured":"Arends CM, Weiss M, Christen F, Eulenberg-Gustavus C, Rousselle A, Kettritz R, Eckardt KU, Chan W, Hoyer K, Frick M, et al. Clonal hematopoiesis in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis. Haematologica. 2020;105(6):e264\u20137.","journal-title":"Haematologica"},{"issue":"36\u201341","key":"3014_CR9","first-page":"e33","volume":"80","author":"CRC Zhang","year":"2019","unstructured":"Zhang CRC, Nix D, Gregory M, Ciorba MA, Ostrander EL, Newberry RD, Spencer DH, Challen GA. Inflammatory cytokines promote clonal hematopoiesis with specific mutations in ulcerative colitis patients. Exp Hematol. 2019;80(36\u201341):e33.","journal-title":"Exp Hematol"},{"key":"3014_CR10","doi-asserted-by":"publisher","first-page":"873896","DOI":"10.3389\/fonc.2022.873896","volume":"12","author":"C Cumbo","year":"2022","unstructured":"Cumbo C, Tarantini F, Zagaria A, Anelli L, Minervini CF, Coccaro N, Tota G, Impera L, Parciante E, Conserva MR, et al. Clonal hematopoiesis at the crossroads of inflammatory bowel diseases and hematological malignancies: a biological link? Front Oncol. 2022;12:873896.","journal-title":"Front Oncol"},{"issue":"17","key":"3014_CR11","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","volume":"341","author":"T Sakane","year":"1999","unstructured":"Sakane T, Takeno M, Suzuki N, Inaba G. Behcet\u2019s disease. N Engl J Med. 1999;341(17):1284\u201391.","journal-title":"N Engl J Med"},{"issue":"3","key":"3014_CR12","doi-asserted-by":"publisher","first-page":"301","DOI":"10.5217\/ir.2020.00013","volume":"19","author":"Y Suzuki","year":"2021","unstructured":"Suzuki Y, Hagiwara T, Kobayashi M, Morita K, Shimamoto T, Hibi T. Long-term safety and effectiveness of adalimumab in 462 patients with intestinal Behcet\u2019s disease: results from a large real-world observational study. Intest Res. 2021;19(3):301\u201312.","journal-title":"Intest Res"},{"issue":"44","key":"3014_CR13","doi-asserted-by":"publisher","first-page":"e17735","DOI":"10.1097\/MD.0000000000017735","volume":"98","author":"X Wang","year":"2019","unstructured":"Wang X, Peng Y, Gao J, Han S, Li Y. Risk of malignancy in Behcet disease: a meta-analysis with systematic review. Medicine (Baltimore). 2019;98(44):e17735.","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"3014_CR14","doi-asserted-by":"publisher","first-page":"469","DOI":"10.5217\/ir.2019.09141","volume":"18","author":"Y Mori","year":"2020","unstructured":"Mori Y, Iwamoto F, Ishida Y, Kuno T, Kobayashi S, Yoshida T, Yamaguchi T, Sato T, Sudo M, Ichikawa D, et al. Long-term outcome after surgery in a patient with intestinal Behcet\u2019s disease complicated by myelodysplastic syndrome and trisomy 8. Intest Res. 2020;18(4):469\u201375.","journal-title":"Intest Res"},{"issue":"3","key":"3014_CR15","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/jdv.12107","volume":"28","author":"International Team for the Revision of the International Criteria for Behcet\u2019s D","year":"2014","unstructured":"International Team for the Revision of the International Criteria for Behcet\u2019s D. The International Criteria for Behcet\u2019s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol. 2014;28(3):338\u201347.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"10","key":"3014_CR16","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1038\/ajg.2009.331","volume":"104","author":"JH Cheon","year":"2009","unstructured":"Cheon JH, Kim ES, Shin SJ, Kim TI, Lee KM, Kim SW, Kim JS, Kim YS, Choi CH, Ye BD, et al. Development and validation of novel diagnostic criteria for intestinal Behcet\u2019s disease in Korean patients with ileocolonic ulcers. Am J Gastroenterol. 2009;104(10):2492\u20139.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"3014_CR17","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s40778-018-0133-9","volume":"4","author":"SJ Park","year":"2018","unstructured":"Park SJ, Bejar R. Clonal hematopoiesis in aging. Curr Stem Cell Rep. 2018;4(3):209\u201319.","journal-title":"Curr Stem Cell Rep"},{"issue":"21","key":"3014_CR18","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1200\/JCO.2011.34.8540","volume":"29","author":"SY Kristinsson","year":"2011","unstructured":"Kristinsson SY, Bjorkholm M, Hultcrantz M, Derolf AR, Landgren O, Goldin LR. Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes. J Clin Oncol. 2011;29(21):2897\u2013903.","journal-title":"J Clin Oncol"},{"issue":"7","key":"3014_CR19","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1042\/CS20200306","volume":"135","author":"L Mooney","year":"2021","unstructured":"Mooney L, Goodyear CS, Chandra T, Kirschner K, Copland M, Petrie MC, Lang NN. Clonal haematopoiesis of indeterminate potential: intersections between inflammation, vascular disease and heart failure. Clin Sci (Lond). 2021;135(7):991\u20131007.","journal-title":"Clin Sci (Lond)"},{"issue":"11","key":"3014_CR20","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1182\/bloodadvances.2019000770","volume":"4","author":"L Busque","year":"2020","unstructured":"Busque L, Sun M, Buscarlet M, Ayachi S, Feroz Zada Y, Provost S, Bourgoin V, Mollica L, Meisel M, Hinterleitner R, et al. High-sensitivity C-reactive protein is associated with clonal hematopoiesis of indeterminate potential. Blood Adv. 2020;4(11):2430\u20138.","journal-title":"Blood Adv"},{"issue":"15","key":"3014_CR21","doi-asserted-by":"publisher","first-page":"3550","DOI":"10.1182\/bloodadvances.2020001582","volume":"4","author":"H Guermouche","year":"2020","unstructured":"Guermouche H, Ravalet N, Gallay N, Deswarte C, Foucault A, Beaud J, Rault E, Saindoy E, Lachot S, Martignoles JA, et al. High prevalence of clonal hematopoiesis in the blood and bone marrow of healthy volunteers. Blood Adv. 2020;4(15):3550\u20137.","journal-title":"Blood Adv"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-023-03014-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-023-03014-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-023-03014-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T09:08:48Z","timestamp":1677748128000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-023-03014-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,2]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3014"],"URL":"https:\/\/doi.org\/10.1186\/s13075-023-03014-w","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,2]]},"assertion":[{"value":"28 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients provided informed consent in accordance with the Declaration of Helsinki guidelines. This study was approved by the ethics committee of the Seoul National University Hospital Healthcare System Gangnam Center (no. 1980\u2013121-1056), Institutional Review Board of Seoul National University (no. 1606\u2013116-772), and Severance Hospital (no. 2012\u20130039-030).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33"}}